Temple University Health System’s preparations for and treatment of patients amidst the coronavirus pandemic continue to be part of the media’s COVID-19 coverage.
- Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, Clinical Professor and Director of the Postgraduate Year Two Infectious Diseases Residency at the Temple University School of Pharmacy and Clinical Pharmacist Specialist in Infectious Diseases at Temple University Hospital, spoke with Politico Pro for an article about antibiotic use to treat COVID-19 and the fear that has raised about antimicrobial resistance.
- Dr. Gallagher also provided perspective to Healio Infectious Disease about Paxlovid, an oral antiviral medication for COVID-19.